Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia
Not available.
Shranjeno v:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2025-07-01
|
| Serija: | Haematologica |
| Online dostop: | https://haematologica.org/article/view/12177 |
| Oznake: |
Brez oznak, prvi označite!
|